Slowdown In Mass Spec Sales at ABI Abets Slide in Tool Sales in Fiscal Q1 | GenomeWeb
Applied Biosystems this week reported that a slowdown in mass spectrometry sales during its fiscal first quarter contributed to a 4-percent decline in overall instrument sales, though the company managed to post a 5.2-percent increase in total revenues for the period.
 
Total receipts for the three months ended Sept. 30 increased to $501.2 million from $476.3 million one year ago. In a conference call accompanying the earnings release, company officials said the results were largely in line with expectations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.